Patent · US Active

Compositions and methods for antibodies targeting EPO

US10385127B2 · kind B2 · utility

1Cited by

4References

19Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Joy Ghosh · Boston, US
Mark Rutz · Martinsried, DE
Kathrin Ulrike Tissot-Daguette · Schwanau, DE
Igor Splawski · Winchester, US
Michael Roguska · Cambridge, US

Key dates

Filing date	Sep 13, 2018
Grant date	Aug 20, 2019
Priority date	—
Expiry date	Sep 13, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to compositions and methods for the inhibition of EPO. The invention provides antibodies and antigen binding fragments thereof that bind to EPO and are able to inhibit EPO-dependent cell proliferation and/or EPO-dependent cell signaling.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.